ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

Regarding infrastructure, Weil pointed to OpenAI’s $500 billion Stargate initiative, which is aimed at expanding U.S. energy ...

ICON's 2025 revenue guidance is $8.05 billion–$8.65 billion, a 1% growth midpoint, versus consensus $8.5 billion. Adjusted EPS for 2025 is forecasted at $13.00–$15.00, flat compared to 2024 ...

The ICON group defined tears as a macroscopic (as opposed to ... With respect to this, the Groningen statement is consistent with previous Delphi studies and clinical guidelines which include ...

Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

Those who knew Bridgette Hempstead describe her as a warrior for Africa-American women diagnosed with breast cancer.

Those who knew Bridgette Hempstead describe her as a warrior for African-American women diagnosed with breast cancer.